Financials

  • Market Capitalization 7 M
  • Employee 10
  • Founded 2003
  • CEO N/A
  • Website www.ensysce.com
  • Headquarter Delaware, United States
  • FIGI BBG00JFF4174
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.23
Price to sales ratio
0.46

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4859
CURX
Curanex Pharmaceuticals Inc - Common Stock
4.53 USD-3.82%+1959.09%+2165.00%+19.21%7.10 M USD
4862
ALZN
Alzamend Neuro, Inc. - Common Stock
1.47 USD-5.77%-5.16%+8.89%-40.00%7.04 M USD
4873
IMRN
Immuron Limited - American Depositary Shares
1.13 USD-0.88%+4.63%+0.89%-37.22%6.61 M USD
4875
LIMN
Liminatus Pharma, Inc. - Class A Common Stock
4.68 USD-9.13%+3242.86%+4154.55%+42.68%6.29 M USD

Frequently asked questions about Ensysce Biosciences, Inc. Common Stock

What is the Ensysce Biosciences, Inc. Common Stock stock price today?

The current price of Ensysce Biosciences, Inc. Common Stock (ENSC) is 0.36. Over the past 24 hours, the stock has changed by -2.70%. Follow the ENSC chart for real-time price dynamics.

What is the stock ticker of Ensysce Biosciences, Inc. Common Stock?

Ensysce Biosciences, Inc. Common Stock trades under the ticker ENSC. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Ensysce Biosciences, Inc. Common Stock stock going up?

ENSC has changed by -2.70% over the last week, +38.46% over the last month, and -5.88% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Ensysce Biosciences, Inc. Common Stock?

Ensysce Biosciences, Inc. Common Stock currently has a market capitalization of 7 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Ensysce Biosciences, Inc. Common Stock earnings last quarter?

Last quarter, Ensysce Biosciences, Inc. Common Stock reported earnings of -0.2 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Ensysce Biosciences, Inc. Common Stock revenue for the last quarter?

Ensysce Biosciences, Inc. Common Stock reported quarterly revenue of 1.16 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Ensysce Biosciences, Inc. Common Stock net income for the last quarter?

Ensysce Biosciences, Inc. Common Stock reported net income of -2.57 M for the last quarter. The previous quarter showed -3.56 M, which means net income changed by +27.71%.

How many employees does Ensysce Biosciences, Inc. Common Stock have?

As of the latest available data, Ensysce Biosciences, Inc. Common Stock has 10 employees. Workforce size can provide additional context about the company's scale and operations.

What is Ensysce Biosciences, Inc. Common Stock EBITDA?

Ensysce Biosciences, Inc. Common Stock EBITDA is -2.57 M, and its EBITDA margin is -220.72%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Ensysce Biosciences, Inc. Common Stock stock?

You can buy Ensysce Biosciences, Inc. Common Stock (ENSC) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Ensysce Biosciences, Inc. Common Stock stock?

Investing in Ensysce Biosciences, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ENSC chart and related analysis on metatrader.com as part of your research.

News